A nearly 90% pullback from its all-time highs has brought Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) down to its record lows. The selloff in TGODF comes as Canada’s regulated cannabis industry struggles with a number of headwinds.
First, Canadian authorities aren’t approving the opening of new cannabis retail outlets fast enough. For instance, in Ontario, Canada’s most populous province with a population of more than 14 million people, there are just 24 cannabis shops. That means that while there is demand for cannabis in Canada, the shortage of shops, getting the products to customers remains a major challenge. In turn, that limits sales for cannabis producers like TGODF.
In addition to the shortage of cannabis shops, black market is another headwind that Canada’s regulated cannabis businesses like TGODF have run into. Experts estimates that black market accounts for 86% of cannabis sales in Canada, thereby chocking the regulated market.
In response to the sluggish development of Canada’s regulated cannabis market, which is caused by shortage of cannabis shops, TGODF has decided to slow down investment in its production capacity expansion.
Slowing down capacity expansion will see TGODF cut back on spending. In turn, the company expects this move and other actions in plans to take will reduce its cash burn and set it firmly on the path to profitability in the near-term.
“With the current Canadian legal market being smaller than initially anticipated, mainly due to a slow rollout of retail locations in key provinces, we believe that our revised plan will allow TGOD [TGODF] to right size its production to capture the organic segment, while maintaining optionality to quickly accelerate and expand as more retail locations begin to open,” Brian Athaide, CEO of TGODF stated.
Even as it slows down capacity expansion, TGODF is preparing to take advantage of Canada’s expanded cannabis market. For example, the company plans to bring a range of new cannabis-related products in December. Moreover, TGODF plans to launch liquid beverages and topicals in 2020.
TGODF bills itself as a premium global organic cannabis products company. Initially focused on Canada’s medical cannabis market, TGODF has expanded into recreational cannabis market as well. In addition to Canada, TGODF also operates in Europe, the Caribbean, and Latin America.
Recent developments at TGODF
- TGODF entered the Ontario market to a rousing welcome. TGODF says initial demand for its premium organic cannabis products is exceeding expectation in Ontario. The company launched in Ontario at the end of August, with that marking its entry into Canada’s recreational cannabis market. Canada’s cannabis market is set to expand more in the coming months. The law legalizing sale of more recreational cannabis products such as vape pens took effect in Canada recently.
“We are thrilled to witness such strong sales and positive feedback from retailers and consumers across Ontario, Canada’s most populous province at 14.32 million people,” commented Brian Athaide, CEO of TGODF.
- Pharmacokinetic study of a proprietary ingredient technology that TGODF intends to commercial returned positive results. The ingredient technology, called Caliper CBD, is owned by a firm known as Caliper Foods. Caliper CBD is a formulation that seeks to simplify adding cannabinoids to any food or beverage. TGODF and Caliper Foods plan to conduct more studies on Caliper CBD, including one that will involve a leading US academic institution. TGODF struck a deal with Caliper Foods to gain exclusive rights to commercialize Caliper CBD in Canada and other international markets outside the US.
“Caliper CBD provides a higher and faster absorption level…it opens a number of possibilities for both the medical and adult-use markets,” commented Rav Kumar, Chief Science Officer at TGODF.
- TGODF has changed some aspects of the agreement it struck with Aurora Cannabis (ACB). Consequently, TGODF expects the change to boost its revenue and profit margin because Aurora will no longer be entitled to take a cut of some of its cannabis products sales. TGODF said the agreement it had with Aurora helped it a lot during its initial development phase. However, changing that agreement became necessary as TGODF matures and its strategies evolve.
The selloff that has set TGODF to its record lows has nothing to do with the company’s fundamentals. TGODF is a victim of the general panic that has gripped Canada’s regulated cannabis industry over the headwinds we’ve discussed. If the measures TGODF has put in place to power its sales are anything to go by, then the pullback provides an opportunity to enter the stock at a steep discount.
We will be updating our subscribers as soon as we know more. For the latest updates on TGODF, sign up below!
Disclosure: We have no position in TGODF and have not been compensated for this article.
Why the ACMPR Is So Popular with Medical Marijuana Patients in Canada
Depending on your home country, accessing medical marijuana may just be easier than ever for you. This is the case for North Americans, Canadians in particular. Since the early 2000s, Canada has been successfully implementing a medical marijuana program for patients called the ACMPR.
Although this program (also referred to as the MMPR and MMAR in the past) has been around in some form or another for decades, it is continuing to grow in popularity. But why? It’s not just because Canadians want an excuse to grow cannabis plants from home…
What Is the ACMPR?
Before discussing the growing popularity of the ACMPR program, it’s important to have a solid understanding of what it actually is. ACMPR stands for Access to Cannabis for Medical Purposes Regulations. For those who are eligible and have a valid medical condition that requires the use of cannabis for treatment, the ACMPR allows for easy access to cannabis.
Not only does it allow medical patients to easily access medical-grade marijuana from licensed producers throughout the country, but it allows patients to cultivate their own plants from home. Unlike the recreational cannabis laws which allow citizens to grow no more than 4 plants from home, the ACMPR determines plant counts based on medical needs.
Canadians who use the ACMPR license to grow from home have a predetermined plant count based on the number of grams prescribed per day. For example, if you receive a prescription…
Why Buy From Marijuana Seed Banks?
If you’re interested in growing marijuana and live in a state that allows its cultivation, then you might want to consider buying seeds from seed banks. Some of the best cannabis get cultivated outside the country, which means that, sometimes, you have to find a seed bank that ships to the US.
There are a lot of options when it comes to sources for marijuana seeds online. However, not all of them can ship to the US due to strict regulations in the country. Thus, it’s best to find a legit seed bank that can process orders from United States customers.
Avoid transacting with other sources aside from seed banks. If you do so, you run the risk of receiving low-quality products, wasting your money in the end. Look for a company with positive feedback and has a proven history of dealing with US customers. Some of the most popular ones include Seedsman and I Love Growing Marijuana (IGLM). You can check out GreenBudGuru’s Seedsman review and their review of other companies to find the best fit for your needs.
If you’re looking to get your seeds online, below are some reasons you should buy marijuana seeds from a trusted and reliable marijuana seed banks.
You Don’t Have Any Other Option
As mentioned above, some states in the US still don’t allow local buying and selling of marijuana, even if medical marijuana consumption has already gained momentum. If…
22nd Century Group Inc (NYSE:XXII): 3 Reasons You May Want To Buy The Stock This Month
The tobacco industry is huge and growing. The cannabis industry is already booming yet it is only in the early stages of development and the future looks incredibly bright as more countries legalize pot. 22nd Century Group Inc (NYSE:XXII) is the stock that offers investors the chance to own the best of both tobacco and cannabis worlds.
The stock currently trades at $1.00/share. But that is not where it belongs as that is its lowest watermark. As recently as September, NYSE:XXII was trading above $2.40/share.
For investors who may have just come across 22nd Century Group for the very first time, here is a brief profile of the company. 22nd Century Group is a plant biotechnology company and a leader in tobacco harm reduction. It has also set its sight on the legal hemp and cannabis industries. In the tobacco space, NYSE:XXII has developed a low-nicotine tobacco plant variety. In the hemp/cannabis space, the company is working to develop hemp and cannabis plants with specific desirable qualities.
If you are looking to have a footing in both tobacco and cannabis industries, here are three reasons you may want to buy NYSE:XXII.
- 22nd Century Group on track to take control of CBD products maker Panacea Life Sciences
On December 3, 22nd Century…